Zentalis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.About ZNTL
Zentalis Pharmaceuticals, Inc. is a clinical oncology innovator developing an oral, non-chemotherapy, biomarker-driven treatment approach for ovarian cancer and multiple tumor types. The therapeutics development and biomarker expertise is advancing monotherapy and combination studies of its investigational potential first-in-class WEE1 inhibitor, azenosertib.
ZNTL Key Statistics
Stock Snapshot
With a market cap of 317.85M, Zentalis Pharmaceuticals(ZNTL) trades at $4.46. The stock has a price-to-earnings ratio of -2.57.
As of 2026-07-05, Zentalis Pharmaceuticals(ZNTL) stock has fluctuated between $4.33 and $4.56. The current price stands at $4.46, placing the stock +3.0% above today's low and -2.1% off the high.
The Zentalis Pharmaceuticals(ZNTL)'s current trading volume is 583.6K, compared to an average daily volume of 1.83M.
During the past year, Zentalis Pharmaceuticals(ZNTL) stock moved between $1.15 at its lowest and $6.95 at its peak.
During the past year, Zentalis Pharmaceuticals(ZNTL) stock moved between $1.15 at its lowest and $6.95 at its peak.
Analyst ratings
56%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.